Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8938722rdf:typepubmed:Citationlld:pubmed
pubmed-article:8938722lifeskim:mentionsumls-concept:C0026882lld:lifeskim
pubmed-article:8938722lifeskim:mentionsumls-concept:C0109278lld:lifeskim
pubmed-article:8938722lifeskim:mentionsumls-concept:C1704675lld:lifeskim
pubmed-article:8938722lifeskim:mentionsumls-concept:C1413043lld:lifeskim
pubmed-article:8938722lifeskim:mentionsumls-concept:C1709915lld:lifeskim
pubmed-article:8938722lifeskim:mentionsumls-concept:C0439799lld:lifeskim
pubmed-article:8938722lifeskim:mentionsumls-concept:C0205099lld:lifeskim
pubmed-article:8938722lifeskim:mentionsumls-concept:C1879547lld:lifeskim
pubmed-article:8938722pubmed:issue7lld:pubmed
pubmed-article:8938722pubmed:dateCreated1997-3-11lld:pubmed
pubmed-article:8938722pubmed:abstractTextCharybdotoxin is a small peptide blocker of K+ channels, rigidly held in active conformation by three disulfide bonds. The toxin blocks K+ channels by binding to a receptor site located at the external "vestibule", and thus physically occluding the outer opening of the K+ conduction pore. In the blocked complex, K27, a residue on the toxin's molecular surface, projects its epsilon-amino group into the K(+)-selective pore. The results here show that CTX, produced by heterologous expression in E. coli, may be manipulated to place unnatural positively charged residues at position 27. The toxin folds faithfully to its native conformation when the crucial lysine at position 27 is replaced by a cysteine residue, a maneuver that allows specific chemical modification of this side-chain. Replacements of K27 by side-chains slightly shorter or slightly longer than lysine yield active toxins. The toxin variant with ornithine at this position interacts much less strongly with K+ ions in the pore of slowpoke-type Ca2(+)-activated K+ channels than does wild-type toxin. This result argues that the epsilon-amino group of K27 in bound toxin lies only a few ångstroms away from a K+ ion occupying the blocked pore. The peptide folds with high efficiency to form the correct disulfides even in the presence of strong denaturants.lld:pubmed
pubmed-article:8938722pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8938722pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8938722pubmed:languageenglld:pubmed
pubmed-article:8938722pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8938722pubmed:citationSubsetIMlld:pubmed
pubmed-article:8938722pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8938722pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8938722pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8938722pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8938722pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8938722pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8938722pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8938722pubmed:statusMEDLINElld:pubmed
pubmed-article:8938722pubmed:issn0028-3908lld:pubmed
pubmed-article:8938722pubmed:authorpubmed-author:MillerCClld:pubmed
pubmed-article:8938722pubmed:authorpubmed-author:ECOTBBlld:pubmed
pubmed-article:8938722pubmed:authorpubmed-author:KozlowskiEElld:pubmed
pubmed-article:8938722pubmed:authorpubmed-author:ShimonyEElld:pubmed
pubmed-article:8938722pubmed:authorpubmed-author:NainiA AAAlld:pubmed
pubmed-article:8938722pubmed:authorpubmed-author:ShaikhTTlld:pubmed
pubmed-article:8938722pubmed:issnTypePrintlld:pubmed
pubmed-article:8938722pubmed:volume35lld:pubmed
pubmed-article:8938722pubmed:ownerNLMlld:pubmed
pubmed-article:8938722pubmed:authorsCompleteYlld:pubmed
pubmed-article:8938722pubmed:pagination915-21lld:pubmed
pubmed-article:8938722pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:8938722pubmed:meshHeadingpubmed-meshheading:8938722-...lld:pubmed
pubmed-article:8938722pubmed:meshHeadingpubmed-meshheading:8938722-...lld:pubmed
pubmed-article:8938722pubmed:meshHeadingpubmed-meshheading:8938722-...lld:pubmed
pubmed-article:8938722pubmed:meshHeadingpubmed-meshheading:8938722-...lld:pubmed
pubmed-article:8938722pubmed:meshHeadingpubmed-meshheading:8938722-...lld:pubmed
pubmed-article:8938722pubmed:meshHeadingpubmed-meshheading:8938722-...lld:pubmed
pubmed-article:8938722pubmed:meshHeadingpubmed-meshheading:8938722-...lld:pubmed
pubmed-article:8938722pubmed:meshHeadingpubmed-meshheading:8938722-...lld:pubmed
pubmed-article:8938722pubmed:meshHeadingpubmed-meshheading:8938722-...lld:pubmed
pubmed-article:8938722pubmed:meshHeadingpubmed-meshheading:8938722-...lld:pubmed
pubmed-article:8938722pubmed:meshHeadingpubmed-meshheading:8938722-...lld:pubmed
pubmed-article:8938722pubmed:meshHeadingpubmed-meshheading:8938722-...lld:pubmed
pubmed-article:8938722pubmed:year1996lld:pubmed
pubmed-article:8938722pubmed:articleTitleInteraction of Ca2(+)-activated K+ channels with refolded charybdotoxins mutated at a central interaction residue.lld:pubmed
pubmed-article:8938722pubmed:affiliationHoward Hughes Medical Institute, Graduate Department of Biochemistry, Brandeis University, Waltham, Massachusetts, USA.lld:pubmed
pubmed-article:8938722pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8938722pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:8938722pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8938722lld:pubmed